SCHEMBL7729499

SCHEMBL7729499

C=CCO[C@@H]1C[C@@H](C(=O)OCC)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.35
P2RX3 P56373 1/20 0.34
FKBP1A P62942 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
UCHL1 P09936 1/20 0.32
TGM2 P21980 2/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
CYP19A1 P11511 1/20 0.31
ABCB1 P08183 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7729501 1.00 NR1H2 (0.35) NR1H2P2RX3FKBP1AMEN1KMT2A
SCHEMBL15590886 0.93 NR1H2 (0.36) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL6848454 0.93 NR1H2 (0.36) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL30732551 0.93 NR1H2 (0.36) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL6848461 0.93 NR1H2 (0.36) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL30556108 0.88 P2RX3 (0.39) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL15697413 0.88 P2RX3 (0.39) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL15674375 0.88 P2RX3 (0.39) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL15674373 0.88 P2RX3 (0.39) NR1H2P2RX3CYP1A2POLBCYP3A4
SCHEMBL85541 0.88 P2RX3 (0.39) NR1H2P2RX3CYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed